The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period. Growth ...

Research and Markets has announced the addition of the "Needle-Free Drug Injection Systems - Global Strategic Business Report" report to their offering. The report provides separate comprehensive ...

Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company who has developed and commercialized an intradermal needle-free platform to more effectively administer drugs and biologics, today announced that ...

Expected Revenue Growth. What This Report Will Provide? Target Audience. Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, ...

Indian pharma eyes promising prospects with needle-free drug delivery transforming patient safety & comfort: Nandita Vijayasimha, Bengaluru Tuesday, January 6, 2026, 09:00 Hrs [IS ...

First self-administered, needle-free injection system approved by Health Canada gives access to safe, painless, cost-effective, and more sustainable drug delivery for chronic illnesses Toronto, ...

Intas collaborates with IntegriMedical to launch India’s first needle-free injection system for IVF and gynaecology: Our ...

Intas has signed an exclusive agreement with SII-backed IntegriMedical to deploy needle-free injection systems across IVF ...

The PharmaJet Tropis Intradermal (ID) Needle-free System will be used exclusively to deliver vaccine to 1.8 million children in upcoming campaign. To date, 12+ million pediatric injections have been ...

The MarketWatch News Department was not involved in the creation of this content. -- Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use ...